Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Cardiovasc Pharmacol ; 66(1): 50-7, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26164720

RESUMO

In fetal human left ventricular endocardial endothelial cells (EECLs), both plasma membrane (PM) ET(A)R and ET(B)R were reported to mediate ET-1-induced increase of intracellular calcium [Ca](i); however, this effect was mediated by ET(A)R in right EECs (EECRs). In this study, we verified whether, as for the PM, nuclear membranes (NMs) ET-1 receptors activation in EECLs and EECRs induce an increase of nuclear calcium ([Ca](n)) and if this effect is mediated through the same receptor type as in PM. Using a plasmalemma-perforated technique and 3D confocal microscopy, our results showed that, as in PM intact cells, superfusion of nuclei of both cell types with cytosolic ET-1 induced a concentration-dependent sustained increase of [Ca](n). In EECRs, the ET(A)R antagonist prevented the effect of ET-1 on [Ca](n) without affecting EECLs. However, in both cell types, the effect of cytosolic ET-1 on [Ca](n) was prevented by the ETBR antagonist. In conclusion, both NMs' ET(A)R and ET(B)R mediated the effect of cytosolic ET-1 on [Ca](n) in EECRs. In contrast, only NMs' ET(B)R activation mediated the effect of cytosolic ET-1 in EECLs. Hence, the type of NMs' receptors mediating the effect of ET-1 on [Ca](n) are different from those of PM mediating the increase in [Ca](i).


Assuntos
Cálcio/metabolismo , Núcleo Celular/metabolismo , Células Endoteliais/metabolismo , Endotelina-1/farmacologia , Membrana Nuclear/fisiologia , Receptor de Endotelina B/fisiologia , Núcleo Celular/efeitos dos fármacos , Células Cultivadas , Endocárdio/efeitos dos fármacos , Endocárdio/metabolismo , Células Endoteliais/efeitos dos fármacos , Antagonistas dos Receptores de Endotelina/farmacologia , Ventrículos do Coração , Humanos , Membrana Nuclear/efeitos dos fármacos
2.
Peptides ; 26(8): 1427-35, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16042982

RESUMO

Evidence suggests that endocardial endothelial cells (EECs) may play a role in the regulation of cardiac function by releasing ET-1. Furthermore, reports in the literature suggested that differences may exist in peptide receptor distribution between the left and right EECs. In this study, we verified if the distribution and density of ET-1 and its receptors could be different in right as compared to left ventricular EECs, and whether this difference may affect ET-1-induced increase of intracellular calcium. Using immunofluorescence and 3D confocal microscopy, our results showed that in both cell types, the ET(A) receptor is present and is homogeneously distributed throughout the two cell types. The relative density of the ET(A) receptor is similar in both right and left ventricular EECs. The ET(B) receptor is also present in right and left ventricular EECs, however, the relative density of the ET(B) receptor is higher in the nucleus as compared to the cytosol. In addition, the ET(B) receptor density was found to be higher in left EECs as compared to right EECs. In addition, our results showed that ET-1 is present in the cytosol and the nucleus of both types of cells and that the relative density of ET-1 is higher in right as compared to left ventricular EECs. Moreover, using the Fura-2 calcium measurement technique, our results showed that in left ventricular EECs, both ET(A) and ET(B) receptor activation mediated the effect of ET-1 on intracellular calcium, whereas in right ventricular EECs, this effect was solely mediated by the ET(A) receptor. In conclusion, our results showed that ET-1 and its receptors are present in both right and left ventricular EECs. However, the distribution and relative density of ET-1 and its receptors seem to be different in right EECs as compared to left EECs.


Assuntos
Endocárdio/citologia , Células Endoteliais/metabolismo , Endotelina-1/metabolismo , Ventrículos do Coração/citologia , Receptor de Endotelina A/metabolismo , Receptor de Endotelina B/metabolismo , Cálcio/metabolismo , Células Cultivadas , Endocárdio/efeitos dos fármacos , Endocárdio/embriologia , Células Endoteliais/citologia , Células Endoteliais/efeitos dos fármacos , Antagonistas do Receptor de Endotelina A , Antagonistas do Receptor de Endotelina B , Ventrículos do Coração/efeitos dos fármacos , Ventrículos do Coração/embriologia , Humanos , Oligopeptídeos/farmacologia , Especificidade de Órgãos/fisiologia , Peptídeos Cíclicos/farmacologia , Piperidinas/farmacologia
3.
Can J Physiol Pharmacol ; 84(3-4): 299-307, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16902577

RESUMO

Neuropeptide Y (NPY), endothelin-1 (ET-1), and angiotensin II (Ang II) are peptides that are known to play many important roles in cardiovascular homeostasis. The physiological actions of these peptides are thought to be primarily mediated by plasma membrane receptors that belong to the G-protein-coupled receptor superfamily. However, there is increasing evidence that suggests the existence of functional G-protein-coupled receptors at the level of the nucleus and that the nucleus could be a cell within a cell. Here, we review our work showing the presence in the nucleus of the NPY Y(1) receptor, the ET(A) and ET(B) receptors, as well as the AT(1) and AT(2) receptors and their respective ligands. This work was carried out in 20-week-old fetal human endocardial endothelial cells. Our results demonstrate that nuclear Y1, AT(1), and ET(A) receptors modulate nuclear calcium in these cells.


Assuntos
Cálcio/metabolismo , Células Endoteliais/metabolismo , Endocárdio/citologia , Endocárdio/metabolismo , Humanos , Receptor Tipo 1 de Angiotensina/metabolismo , Receptor Tipo 2 de Angiotensina/metabolismo , Receptor de Endotelina A/metabolismo , Receptor de Endotelina B/metabolismo , Receptores de Neuropeptídeo Y/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA